Andon Health Co.Ltd(002432) disclose performance forecast. The company expects to make a profit of 90-120 million yuan in 2021, an increase of 271.40% – 395.19% over the same period of last year. The company’s New Coronavirus (SARS-CoV-2) antigen self testing OTC kit product sales in the United States market has increased significantly, prompting a significant increase in operating performance in 2021.
[ company report ]
Andon Health Co.Ltd(002432) : the monthly performance of kit products does not represent the annual performance
Shanghai Securities News China Securities Network (reporter Luo min) Andon Health Co.Ltd(002432) disclosed that the stock trading risk warning announcement said that the single month performance of the kit product does not represent the annual performance, and the historical performance of the product does not represent the future performance. The sales information disclosed by the company in the previous announcement cannot represent the profit. Because the profit is related to many factors such as raw material cost, product transportation cost, production and manufacturing cost, sales cost, management cost and R & D cost, it is impossible to calculate the profit from the sales amount. Please pay attention to the subsequent announcement of the company for the relevant information of the company’s performance.
Andon Health Co.Ltd(002432) : the subsidiary covid-19 antigen rapid detection POC professional kit product has been authorized by FDA for emergency use
Shanghai Securities News China Securities Network (reporter Kong Ziyuan) Andon Health Co.Ltd(002432) announced that ihealth labs Inc, an American subsidiary of the company, is authorized by the U.S. Food and Drug Administration (FDA). The New Coronavirus (SARS-CoV-2) antigen was rapidly detected by the POC (Point Of Care) professional version of the kit (colloidal gold immunochromatography), and the authorized authorization letter was received from the US FDA to iHealth America. After obtaining the U.S. emergency use authorization (EUA), the product can be used in the United States and countries / regions that recognize the U.S. FDA EUA during the U.S. public health emergency state.
